These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22924642)

  • 1. Human embryonic stem cell-derived mesodermal progenitors display substantially increased tissue formation compared to human mesenchymal stem cells under dynamic culture conditions in a packed bed/column bioreactor.
    de Peppo GM; Sladkova M; Sjövall P; Palmquist A; Oudina K; Hyllner J; Thomsen P; Petite H; Karlsson C
    Tissue Eng Part A; 2013 Jan; 19(1-2):175-87. PubMed ID: 22924642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human embryonic mesodermal progenitors highly resemble human mesenchymal stem cells and display high potential for tissue engineering applications.
    de Peppo GM; Svensson S; Lennerås M; Synnergren J; Stenberg J; Strehl R; Hyllner J; Thomsen P; Karlsson C
    Tissue Eng Part A; 2010 Jul; 16(7):2161-82. PubMed ID: 20136402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteogenic potential of human mesenchymal stem cells and human embryonic stem cell-derived mesodermal progenitors: a tissue engineering perspective.
    de Peppo GM; Sjovall P; Lennerås M; Strehl R; Hyllner J; Thomsen P; Karlsson C
    Tissue Eng Part A; 2010 Nov; 16(11):3413-26. PubMed ID: 20536357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential bone-forming capacity of osteogenic cells from either embryonic stem cells or bone marrow-derived mesenchymal stem cells.
    Both SK; van Apeldoorn AA; Jukes JM; Englund MC; Hyllner J; van Blitterswijk CA; de Boer J
    J Tissue Eng Regen Med; 2011 Mar; 5(3):180-90. PubMed ID: 20718035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient engineering of vascularized ectopic bone from human embryonic stem cell-derived mesenchymal stem cells.
    Domev H; Amit M; Laevsky I; Dar A; Itskovitz-Eldor J
    Tissue Eng Part A; 2012 Nov; 18(21-22):2290-302. PubMed ID: 22731654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic cultivation of human mesenchymal stem cells in a rotating bed bioreactor system based on the Z RP platform.
    Diederichs S; Röker S; Marten D; Peterbauer A; Scheper T; van Griensven M; Kasper C
    Biotechnol Prog; 2009; 25(6):1762-71. PubMed ID: 19795480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of bioreactors for culture of fetal mesenchymal stem cells for bone tissue engineering.
    Zhang ZY; Teoh SH; Teo EY; Khoon Chong MS; Shin CW; Tien FT; Choolani MA; Chan JK
    Biomaterials; 2010 Nov; 31(33):8684-95. PubMed ID: 20739062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of murine embryonic stem cells, alginate encapsulation, and rotary microgravity bioreactor in bone tissue engineering.
    Hwang YS; Cho J; Tay F; Heng JY; Ho R; Kazarian SG; Williams DR; Boccaccini AR; Polak JM; Mantalaris A
    Biomaterials; 2009 Feb; 30(4):499-507. PubMed ID: 18977027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow perfusion culture of human mesenchymal stem cells on silicate-substituted tricalcium phosphate scaffolds.
    Bjerre L; Bünger CE; Kassem M; Mygind T
    Biomaterials; 2008 Jun; 29(17):2616-27. PubMed ID: 18374976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfusion bioreactor system for human mesenchymal stem cell tissue engineering: dynamic cell seeding and construct development.
    Zhao F; Ma T
    Biotechnol Bioeng; 2005 Aug; 91(4):482-93. PubMed ID: 15895382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radial-flow bioreactor enables uniform proliferation of human mesenchymal stem cells throughout a three-dimensional scaffold.
    Katayama A; Arano T; Sato T; Ikada Y; Yoshinari M
    Tissue Eng Part C Methods; 2013 Feb; 19(2):109-16. PubMed ID: 22834782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration.
    Dennis JE; Esterly K; Awadallah A; Parrish CR; Poynter GM; Goltry KL
    Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
    Engelmayr GC; Sales VL; Mayer JE; Sacks MS
    Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A biaxial rotating bioreactor for the culture of fetal mesenchymal stem cells for bone tissue engineering.
    Zhang ZY; Teoh SH; Chong WS; Foo TT; Chng YC; Choolani M; Chan J
    Biomaterials; 2009 May; 30(14):2694-704. PubMed ID: 19223070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone matrix formation in osteogenic cultures derived from human embryonic stem cells in vitro.
    Kärner E; Unger C; Sloan AJ; Ahrlund-Richter L; Sugars RV; Wendel M
    Stem Cells Dev; 2007 Feb; 16(1):39-52. PubMed ID: 17233553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Volloch V; Kaplan DL
    Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel bioreactor for ligament tissue engineering.
    Kahn CJ; Vaquette C; Rahouadj R; Wang X
    Biomed Mater Eng; 2008; 18(4-5):283-7. PubMed ID: 19065035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro culture of large bone substitutes in a new bioreactor: importance of the flow direction.
    Olivier V; Hivart P; Descamps M; Hardouin P
    Biomed Mater; 2007 Sep; 2(3):174-80. PubMed ID: 18458469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Kirker-Head C; Abrahamson L; Gronowicz G; Volloch V; Kaplan DL
    J Biomed Mater Res A; 2006 Dec; 79(3):464-75. PubMed ID: 16752403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor.
    Niebruegge S; Bauwens CL; Peerani R; Thavandiran N; Masse S; Sevaptisidis E; Nanthakumar K; Woodhouse K; Husain M; Kumacheva E; Zandstra PW
    Biotechnol Bioeng; 2009 Feb; 102(2):493-507. PubMed ID: 18767184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.